BeStock  
Stocks › Biotechnology › PRME

Prime Medicine PRME

US equityMarket cap rank #3316Biotechnology
$3.55 −$0.29 (-7.55%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $3.56 +0.28%
Open$3.70
Prev close$3.84
Day range$3.49 – $3.94
Volume6.13M
Market cap$791.62M
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

PRME at a glance

Shares of Prime Medicine are down 7.55% at $3.55. The company is worth $791.62M, number 3316 out of 3753 on our list.

The stock's 52-week band runs $2.67 to $5.91, and the latest print sits 39.9% under the top end of it. Holders are behind 2.2% over twelve months, but up 9.2% across the last three months.

Price is below the 50-day average ($3.74) but above the 200-day ($3.51); RSI is 43, and the last 30 sessions moved at roughly 141% annualized volatility.

Revenue for the quarter ended Sep 2026 was $4.21M, up 243.9% from a year earlier, and a net loss of $39.04M.

6 analysts follow the stock and the average call is "buy". The mean target, $8.20, sits 131.0% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$3.56 / $3.65
Average price today$3.63
Volume6.13MAvg (90d) 4.10M
Turnover$22.28M
Turnover rate4.06%of shares outstanding
Volume ratio1.19vs. recent average pace
Day amplitude11.72%
Market cap$791.62M
Float market cap$536.44M
Shares outstanding151.11M
EPS (TTM)-$1.35
P/B93.42
Book value / share$0.04
Net profit (TTM)-$301.04M
Net assets$8.47M
30-day volatility140.8%annualized
Avg daily range (ATR)13.69%of price, 14 days
Max drawdown (1y)-42.2%-33.8% from 1y peak

Quote as of Nov 21, 2026 9:10 am ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

C
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

B
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

F
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

6 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 48.3 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth—
Profitability0.6
Momentum58.0
Financial health68.2
Analyst view93.4

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$8.20+131.0% vs. current price
Consensus ratingBuy6 analysts covering
Morningstar fair value$9.24Price is below fair value

Wall Street’s average 12-month target is $8.20, 131.0% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $9.24, so shares trade 61.6% below that estimate. On earnings multiple, it sits in the 29th percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-7.6%
1 week
-16.9%
1 month
-4.8%
3 months
+9.2%
6 months
+19.5%
Year to date
+2.3%
1 year
-2.2%
Day range
$3.49$3.94
52-week range
$2.67$5.91

Technical signals

Full technicals →
Trend readLeaning bearish

2 bullish · 5 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-17.7%Bearish
Price vs 50-day average-5.0%Bearish
Price vs 200-day average+1.2%Bullish
50-day vs 200-day50d above 200dBullish
RSI (14)43.3Bearish
MACD (12,26,9)-0.02Bearish
Bollinger band position12%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How PRME ranks on BeStock

Market value#3301 of 3734
Closeness to 52-week high#2666 of 3724
Dollar volume today#1940 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

PRME is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on PRME.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on PRME

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

PRME stock: common questions

Where is PRME trading right now?

$3.55 is the latest print for PRME, a move of -7.55% against yesterday's close of $3.84. Today's low and high so far: $3.49 and $3.94.

What is PRME worth in total?

Equity value comes to $791.62M at the current price. By that measure it is number 3316 of the 3753 names in our coverage.

Where does PRME sit in its 52-week range?

The year's floor is $2.67 and the ceiling $5.91. Shares are 39.9% away from that ceiling.

Does PRME send cash back through a dividend?

Our data shows no dividend paid by Prime Medicine over the trailing twelve months.

Do Wall Street analysts like PRME?

Of 6 analysts, 100% say buy, 0% hold and 0% sell. Price targets average $8.20, with the most cautious at $6.00 and the most optimistic at $11.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on PRME.

Sign in to join the discussion.

Scroll to Top